Bigger rebates aren‘t always better.

Welcome back to the second half of the interview with  Ryan Rice and Chris Ziemke from Prism Health Group. Our conversation continues, but we switch gears to the topic of rebates themselves that are oftentimes set forth in a proposal from a PBM. And what we've noticed in those rates is there's been such a degree of escalation over the last five years. Chris says, "you're getting bigger rebates, but you're also spending a lot more in stepping over a dollar to pick up a needle. And that's really not the advised direction that we would take with folks. And we're going to see more of this."   

This concept of the aggregator and the way in which a rebate aggregator works with plan sponsors is emerging in the marketplace, along with the emergence of GPOs or group purchasing organizations.  

You will also hear Prism's advice on the one additional question you should ask that is not typically asked in an RFP. Listen to this episode, Bigger rebates aren’t always better.

Read the rest of this entry »

Drugs and Data – How Analytics Truly Impact Claims Spend

Ryan Rice and Chris Ziemke from Prism Health Group represent a new breed of healthcare consultants, poised to impact the entire healthcare spectrum versus the traditional, siloed approach. They saw the needs in the pharmacy industry specifically to navigate the pharmacy benefit management space. Employers needed a better understanding of their pharmacy spending from an unbiased source. That's where Prism Health Group comes in. Listen to this episode, "Drugs and Data – How Analytics Truly Impact Claims Spend."

Read the rest of this entry »